CoChat

A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder

LYDIARD, R. BRUCE, LESSER, IRA M., BALLENGER, JAMES C., RUBIN, ROBERT T., LARAIA, MICHELE, DUPONT, ROBERT · 1992 · Journal of Clinical Psychopharmacology
Cited by 48

The DOI matches its Crossref record.

Abstract

A recently reported multinational, 8-week double-blind, placebo-controlled study assessing the efficacy of alprazolam versus placebo in the treatment of panic disorder indicated significant differences favoring alprazolam. We now report the results of a three-site, 6-week, double-blind, fixed-dose study comparing alprazolam 2 mg, alprazolam 6 mg, and placebo in 94 patients with panic disorder with or without agoraphobia. Both alprazolam treatment groups (6 mg and 2 mg) improved significantly more than did the placebo treatment group on most outcome measures. Only a few statistically significant differences between the 6 mg and 2 mg alprazolam groups were discerned, although the pattern of treatment response across measures suggested a dose effect. Dropouts in the placebo group were primarily due to lack of efficacy and in the alprazolam 6 mg group were due to side effects, which may have contributed to the limited differences between groups at study end. The findings suggest that many patients may require less than 6 mg of alprazolam per day for effective treatment of panic disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199204000-00004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 48

Metadata

Authors
LYDIARD, R. B., LESSER, I. M., BALLENGER, J. C., RUBIN, R. T., LARAIA, M., & DUPONT, R.
Venue
Journal of Clinical Psychopharmacology
Published
1992-04
Volume
12
Issue
2
Pages
96???103
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2030881630
Cited by
48
References
0
FWCI
5.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder. https://app.cochat.ai/papers/10.1097/00004714-199204000-00004
The paper
LYDIARD, R. B., LESSER, I. M., BALLENGER, J. C., RUBIN, R. T., LARAIA, M., & DUPONT, R. (1992). A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199204000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.